“These CTEs simultaneously attack the tumor while also retaining the activities of an anti-CD19 CAR—utilizing the normal, ever-renewing B-cell population for activation, proliferation, differentiation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results